Patient Advocacy and Oncology: How A Community Cancer Network is Making a Difference

Episode 3 April 20, 2021 00:39:11
Patient Advocacy and Oncology: How A Community Cancer Network is Making a Difference
Trial Talks
Patient Advocacy and Oncology: How A Community Cancer Network is Making a Difference

Apr 20 2021 | 00:39:11

/

Show Notes

Approximately 39.5% of all men and women will be diagnosed with cancer at some point during their lifetimes, and yet only 8% of oncology patients participate in clinical trials. Many industry leaders think that a greater focus on patient advocacy could be the missing link.

In this episode, Rose Gerber, Director of Patient Advocacy and Education at the Community Oncology Alliance – once a patient herself and now a dedicated advocate – will share her story and discuss how patient advocacy is helping to increase patient enrollment in clinical trials across every therapeutic area.

Other Episodes

Episode 4

May 19, 2021 00:22:43
Episode Cover

Achieving Patient Centricity by Removing Barriers in the Clinical Trial Process

Constantly changing regulations and a multitude of new endpoints continue to keep clinical researchers on their toes. While these regulations and endpoints are designed...

Listen

Episode 3

July 26, 2020 00:20:12
Episode Cover

Global Pandemic Challenges & Long-Term Strategies for Preparedness | Synteract

Due to COVID-19 the clinical trial industry has been adopting advanced clinical trial technology at warp speed, but what does this mean for the...

Listen

Episode 1

July 13, 2020 00:27:15
Episode Cover

Why Clinical Trials are Thriving in Australia & New Zealand | Avance Clinical

Australia and New Zealand have not been impacted as much as North America and the EU with regards to COVID-19. For this reason, and...

Listen